C6orf204 antibody (AA 451-550) (AbBy Fluor® 750)

Catalog No. ABIN4998614

Product Details anti-C6orf204 Antibody (AbBy Fluor® 750)

Target: C6orf204 (CEP85L) (Centrosomal Protein 85kDa-Like (CEP85L))

Binding Specificity: AA 451-550

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This C6orf204 antibody is conjugated to AbBy Fluor® 750

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Predicted Reactivity: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C6orf204

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for C6orf204

Target: C6orf204 (CEP85L) (Centrosomal Protein 85kDa-Like (CEP85L))

Alternative Name: C6orf204 (CEP85L Products)

Synonyms: C6orf204 antibody, NY-BR-15 antibody, bA57K17.2 antibody, centrosomal protein 85 like antibody, CEP85L antibody

Background:

Synonyms: bA57K17.2, C6orf204, centrosomal protein 85 kDa-like, CE85L_HUMAN, Coiled-coil domain-containing protein C6orf204, NY-BR-15, RP11-57K17.2, Serologically defined breast cancer antigen NY-BR-15.

Background: Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf204 gene product has been provisionally designated C6orf204 pending further characterization.

Gene ID: 387119